A new oral phosphodiesterase-5 inhibitor Indicated for the treatment of ED

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2012年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：250 / 251
页数：2
相关论文
共 50 条
  • [11] AN INTERNATIONAL COMPARISON OF PHOSPHODIESTERASE-5 INHIBITOR ASSOCIATED MELANOMA
    Mai, K.
    Pham, Q.
    Park, J.
    Kuo, Y.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP149 - NP149
  • [12] The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
    N Mehrotra
    M Gupta
    A Kovar
    B Meibohm
    International Journal of Impotence Research, 2007, 19 : 253 - 264
  • [13] Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia
    Cantrell, Matthew A.
    Baye, Jordan
    Vouri, Scott Martin
    PHARMACOTHERAPY, 2013, 33 (06): : 639 - 649
  • [14] The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
    Mehrotra, N.
    Gupta, M.
    Kovar, A.
    Meibohm, B.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (03) : 253 - 264
  • [15] Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension
    Fisher, Jolene H.
    Johnson, Sindhu R.
    BMath, Cathy Chau
    Kron, Amie T.
    Granton, John T.
    CANADIAN RESPIRATORY JOURNAL, 2015, 22 (01) : 42 - 46
  • [16] Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog
    Serres, F
    Nicolle, AP
    Tissier, R
    Gouni, V
    Pouchelon, JL
    Chetboul, V
    JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2006, 53 (03): : 129 - 133
  • [17] Triple kinase inhibitor with phosphodiesterase-5 inhibitor for idiopathic pulmonary fibrosis
    Kishaba, Tomoo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (11) : 5974 - 5978
  • [18] SERUM TESTOSTERONE LEVEL PRIOR TO COMMENCEMENT OF PHOSPHODIESTERASE-5 INHIBITOR TREATMENT PREDICTS TREATMENT FAILURE
    Ho, Christopher C. K.
    Akhavanmalyeri, Adel
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 216 - 216
  • [19] Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension
    Arif, Sally A.
    Poon, Henry
    CLINICAL THERAPEUTICS, 2011, 33 (08) : 993 - 1004
  • [20] Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine
    Jain, N
    Patil, CS
    Singh, A
    Kulkarni, SK
    PHARMACOLOGY, 2003, 67 (03) : 150 - 156
12345